Sunday share tips: British American Tobacco, Primary Health Props, AJ Bell, SEEIT
A round-up of Sunday's newspaper tips, including British American Tobacco in the Sunday Telegraph, Primary Health Properties in the Sunday Times and both AJ Bell and SEEIT in the Mail on Sunday.
British American Tobacco
2,893.00p
17:15 27/12/24
FTSE 100
8,149.78
16:54 27/12/24
FTSE 250
20,488.65
16:29 27/12/24
FTSE 350
4,495.62
16:29 27/12/24
FTSE All-Share
4,453.14
17:05 27/12/24
Primary Health Properties
92.20p
17:00 27/12/24
Real Estate Investment Trusts
1,995.14
16:29 27/12/24
Tobacco
34,107.17
16:29 27/12/24
Primary Health Properties was tipped as worth buying in the Sunday Times' Inside the City column.
Hundreds of small neighbourhood doctors' surgeries have been replaced by large, modern health centres — often with a pharmacy or physiotherapist attached. Property developers like the long leases and rent guaranteed by the NHS. Primary Healthcare Properties, which floated on AIM in 1996 and moved up to the full list in 1998 and the FTSE 250 last April, owns 308 such centres in the UK and Ireland. Its shares have barely moved since this time last year, which makes it more appealing to investors who want something to "tuck away in the bottom draw".
Expected to pay total dividends of 5.4p this year, PHP offers a yield of just under 5%. The company raised £115m in April to pay down debt and fund growth. Analysts at Peel Hunt have set a 125p target on the stock, while Jefferies has affixed a target price of 126p.
AJ Bell, ahead of its flotation, and SDCL Energy Efficiency Income Trust were both tipped as a 'buy' by Midas in the Mail on Sunday.
AJ Bell plans to float on the Stock Exchange next week prices at 154-166p a share for a valuation of up to £675m, with City institutions and AJ Bell customers all eligible for the offer, with founder Andy Bell's parents, family and friends also subscribing for shares in the initial public offer. Bell himself will see his stake trimmed to 25% from 28% but he will remain the top shareholder following the float.
As a business, AJ Bell is a rival to the likes of FTSE-listed Hargreaves Lansdown and privately owned Interactive Investor. Bell's aims to differ from some of its competitors by offering customers direct access or via financial advisers to gain a broad spread of customers.
Over at SDCL Energy Efficiency Income Trust, known as SEEIT, the aim is to address the issue of around three quarters of energy being lost through inefficient transmission, distribution and end use. The investment fund hopes to raise £150m at 100p per share ahead of first trading on 11 December. The aim is for the shares to deliver an initial 5% dividend yield, ascending to 5.5 % by the year ending March 2021.
The trust, which is managed by Sustainable Development Capital, which has worked with Santander UK, NCP car parks and St Bartholomew’s Hospital in London, plans to use the cash to buy an initial portfolio of 12 energy projects and contracted investment opportunities from a "significant" pipeline in the UK, continental Europe, and North America. Contracts run for up to 20 years.
Projects include cutting energy consumption via LED lighting or insulation, with SDC chief executive and founder Jonathan Maxwell saying: "SEEIT's listing on the London Stock Exchange will provide investors with a unique opportunity to gain exposure to the emerging energy efficiency asset class.
"Both private and public organisations are seeking to reduce their energy consumption footprint and improve security of energy supply, mindful of economic, social and environmental costs."
In the Sunday Telegraph, Questor said that British American Tobacco, having fallen around 45% this year, is "starting to look cheap".
Please note: Digital Look/Sharecast provides a round-up of news, tips and information that is impacting share prices and the market. Digital Look/Sharecast cannot take any responsibility for information provided by third parties. This is for your general information only and not intended to be relied upon by users in making an investment decision or any other decision. Please obtain a copy of the relevant publication and carry out your own research before considering acting on any of this information.